APYX MEDICAL CORP (APYX) Stock Earnings & Estimates
USA - NASDAQ:APYX - US03837C1062 - Common Stock
2.96 USD
+0.01 (+0.34%)
2.92 USD
-0.04 (-1.35%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 44.51M -8.26% | 52.349M 17.61% | 48.102M -8.11% | 51.001M 6.03% | 53.538M 4.97% | 57.12M 6.69% | 73.971M 29.50% | 272.59M 268.51% | 361.19M 32.50% | |
| EBITDA YoY % growth | -22.67M -67.31% | -19.259M 15.05% | -18.246M 5.26% | -6.415M 64.84% | -8.019M -25.00% | -5.916M 26.22% | 14.178M 339.66% | N/A | N/A | |
| EBIT YoY % growth | -23.56M -63.04% | -19.951M 15.32% | -18.845M 5.54% | -9.891M 47.51% | -12.665M -28.04% | -11.73M 7.38% | 1.849M 115.76% | 40.889M 2,111.41% | 72.237M 76.67% | |
| Operating Margin | -52.93% | -38.11% | -39.18% | -19.39% | -23.66% | -20.54% | 2.50% | 15.00% | 20.00% | |
| EPS YoY % growth | -0.67 -52.27% | -0.62 7.46% | -0.67 -8.06% | -0.37 44.05% | -0.43 -13.61% | -0.36 14.97% | -0.03 91.55% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 25.32% | -0.06 53.25% | -0.12 -19.00% | -0.11 -20.89% | -0.11 -4.07% | -0.08 -45.45% | -0.22 -88.57% |
| Revenue Q2Q % growth | 12.242M 6.57% | 17.517M 23.17% | 10.354M 9.80% | 12.403M 9.06% | 12.804M 4.59% | 17.021M -2.83% | N/A |
| EBITDA Q2Q % growth | -2.369M 25.44% | 167.617K 106.84% | -3.464M -18.91% | -2.335M -1.36% | -2.431M -2.60% | -724.71K -532.36% | N/A |
| EBIT Q2Q % growth | -3.234M 11.03% | -896.58K 70.58% | -4.46M -46.18% | -3.458M -34.36% | -3.489M -7.90% | -1.257M -40.22% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.09 52.63% | -0.10 | 0.01 | 5.46% |
| Q1 2025 Q2Q % growth | -0.10 54.55% | -0.12 | 0.02 | 18.30% |
| Q4 2024 Q2Q % growth | -0.12 57.14% | -0.16 | 0.04 | 26.47% |
| Q3 2024 Q2Q % growth | -0.14 -7.69% | -0.19 | 0.05 | 26.05% |
| Q2 2024 Q2Q % growth | -0.19 -72.73% | -0.20 | 0.01 | 6.02% |
| Q1 2024 Q2Q % growth | -0.22 -120.00% | -0.22 | 0.00 | -0.60% |
| Q4 2023 Q2Q % growth | -0.28 -64.71% | -0.18 | -0.10 | -54.57% |
| Q3 2023 Q2Q % growth | -0.13 23.53% | -0.12 | -0.01 | -12.59% |
| Q2 2023 Q2Q % growth | -0.11 31.25% | -0.07 | -0.04 | -55.39% |
| Q1 2023 Q2Q % growth | -0.10 41.18% | -0.14 | 0.04 | 27.38% |
| Q4 2022 Q2Q % growth | -0.17 -183.33% | -0.15 | -0.02 | -16.96% |
| Q3 2022 Q2Q % growth | -0.17 -41.67% | -0.15 | -0.02 | -14.94% |
| Q2 2022 Q2Q % growth | -0.16 -33.33% | -0.19 | 0.03 | 16.34% |
| Q1 2022 Q2Q % growth | -0.17 -21.43% | -0.15 | -0.02 | -13.63% |
| Q4 2021 Q2Q % growth | -0.06 -50.00% | -0.11 | 0.05 | 46.52% |
| Q3 2021 Q2Q % growth | -0.12 -9.09% | -0.15 | 0.03 | 21.57% |
| Q2 2021 Q2Q % growth | -0.12 14.29% | -0.15 | 0.03 | 20.10% |
| Q1 2021 Q2Q % growth | -0.14 30.00% | -0.15 | 0.01 | 3.68% |
| Q4 2020 Q2Q % growth | -0.04 75.00% | -0.11 | 0.07 | 64.99% |
| Q3 2020 Q2Q % growth | -0.11 15.38% | -0.17 | 0.06 | 34.74% |
| Q2 2020 Q2Q % growth | -0.14 -7.69% | -0.22 | 0.08 | 35.41% |
| Q1 2020 Q2Q % growth | -0.20 -42.86% | -0.26 | 0.05 | 21.57% |
| Q4 2019 Q2Q % growth | -0.16 | -0.20 | 0.04 | 18.83% |
| Q3 2019 Q2Q % growth | -0.13 | -0.18 | 0.05 | 29.19% |
| Q2 2019 Q2Q % growth | -0.13 | -0.18 | 0.05 | 29.19% |
| Q1 2019 Q2Q % growth | -0.14 | -0.18 | 0.04 | 23.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 11.373M -6.39% | 11.933M | -560K | -4.69% |
| Q1 2025 Q2Q % growth | 9.43M -7.95% | 9.576M | -146K | -1.52% |
| Q4 2024 Q2Q % growth | 14.222M -3.00% | 13.656M | 566K | 4.14% |
| Q3 2024 Q2Q % growth | 11.487M -4.08% | 11.606M | -119K | -1.03% |
| Q2 2024 Q2Q % growth | 12.149M -10.47% | 11.982M | 167K | 1.39% |
| Q1 2024 Q2Q % growth | 10.244M -15.63% | 9.717M | 527K | 5.42% |
| Q4 2023 Q2Q % growth | 14.662M 16.27% | 15.145M | -483K | -3.19% |
| Q3 2023 Q2Q % growth | 11.976M 31.46% | 15.678M | -3.702M | -23.61% |
| Q2 2023 Q2Q % growth | 13.569M 31.87% | 14.612M | -1.043M | -7.14% |
| Q1 2023 Q2Q % growth | 12.142M -2.79% | 11.084M | 1.058M | 9.55% |
| Q4 2022 Q2Q % growth | 12.61M -25.03% | 13.195M | -585K | -4.43% |
| Q3 2022 Q2Q % growth | 9.11M -22.99% | 12.25M | -3.14M | -25.63% |
| Q2 2022 Q2Q % growth | 10.29M -8.29% | 10.768M | -478K | -4.44% |
| Q1 2022 Q2Q % growth | 12.49M 44.56% | 11.345M | 1.145M | 10.09% |
| Q4 2021 Q2Q % growth | 16.82M 46.77% | 14.919M | 1.901M | 12.74% |
| Q3 2021 Q2Q % growth | 11.83M 70.22% | 10.4M | 1.43M | 13.75% |
| Q2 2021 Q2Q % growth | 11.22M 160.93% | 9.039M | 2.181M | 24.13% |
| Q1 2021 Q2Q % growth | 8.64M 72.80% | 8.375M | 265K | 3.16% |
| Q4 2020 Q2Q % growth | 11.46M 35.46% | 9.808M | 1.652M | 16.84% |
| Q3 2020 Q2Q % growth | 6.95M -8.31% | 5.797M | 1.153M | 19.89% |
| Q2 2020 Q2Q % growth | 4.3M -35.34% | 2.004M | 2.296M | 114.57% |
| Q1 2020 Q2Q % growth | 5M -11.19% | 5.305M | -305K | -5.75% |
| Q4 2019 Q2Q % growth | 8.46M | 8.014M | 446K | 5.57% |
| Q3 2019 Q2Q % growth | 7.58M | 6.918M | 662K | 9.57% |
| Q2 2019 Q2Q % growth | 6.65M | 5.986M | 664K | 11.09% |
| Q1 2019 Q2Q % growth | 5.63M | 5.785M | -155K | -2.68% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.5% | -6.03% | 0.68% | -2.08% |
| Revenue | -0.01% | 2.27% | 0% | 3.7% |